agalactiae and S. pyogenes with MBC of 20 mg/ml, 10 mg/ml and 5 mg/ml, respectively. Lepista nuda extract exhibited a bactericide effect upon P. multocida at 5 mg/ml, and inhibited Proteus mirabilis at 20 mg/ml. Ramaria botrytis extract showed activity against E. faecalis and L. monocytogenes, being bactericide for P. multocida, S. agalactiae (MBCs 20 mg/ml) and S. pyogenes (MBC 10 mg/ml). Leucopaxillus giganteus extract inhibited the growth of E. coli and P. mirabilis, being bactericide for P. multocida, S. pyogenes and S. agalactiae.
Introduction
The prevalence of infectious diseases is becoming a worldwide problem; antimicrobial drugs have long been used for prophylactic and therapeutic purposes, but the drugresistant bacterial strains have creating serious treatment problems (Klein et al. 2007; Steinkraus et al. 2007) . Several studies carried out in Portugal with microorganisms such as MRSA (meticiline-resistant Staphylococcus aureus) (EARSS 2007) , Enterococcus faecalis (Novais et al. 2004) , Enterobacteriaceae (Machado et al. 2007) and Pseudomonas aeruginosa (Cardoso et al. 2002) , revealed their high susceptibility to antimicrobial agents and, moreover, their increasing global virulence. In particular, the incidence of MRSA, in Portuguese hospitals is one of the most important in Europe (45%) (EARSS 2007) .
Recently, Trindade et al. (2009) reported that bacteria develop resistance to antibiotics through genome mutations that are crucial for their survival. Therefore, despite the impossibility to avoid bacteria evolution, it is important to choose the most adequate antibiotics to control such evolution in favor of human host.
The huge increase of resistances associated to diseases and mortality (Shorr et al. 2006) is exerting a considerable pressure in health systems, mainly at hospital level. Besides the multi-resistance problem, the nosocomial infections (health-care associated infections) are associated to high mortality, as also to the increase in the internment period and related costs (Orsi et al. 2002; Masterton et al. 2003; Wisplinghoff et al. 2004; Sǔljagić et al. 2005; Cosgrove 2006) . Disease Control and Prevention (CDC) centers estimate that nosocomial infections are at least ca. 5% in all hospitalized patients, dealing to more than 2 millions of infections and 99.000 deaths per year (Wenzel and Edmond 2001; CDC 2003; CDC 2007) . This situation has forced the research of new antimicrobial substances effective against pathogenic microorganisms resistant to conventional treatments. Natural resources have been exploited in the last years and among them mushrooms could be an alternative as source of new antimicrobials.
The Northeast of Portugal is one of the European regions with higher biodiversity in wild mushrooms, most of them with a great gastronomic importance. Mushrooms have been recognized as functional foods and as a source for the development of medicines and nutraceuticals (Lindequist et al. 2005; Poucheret et al. 2006) . They could also be a source of natural antibiotics. Some mushroom extracts, including Laetiporus sulphureus (Turkoglu et al. 2007) , Ganoderma lucidum (Gao et al. 2005) and Lentinus edodes (Hatvani 2001) have already demonstrated antibacterial activity. Furthermore, some Portuguese species studied by our research group proved to be active against Bacillus cereus, B. subtilis and S. aureus (Barros et al. 2007b; Barros et al. 2008) . Nevertheless, the reports available on literature are not related with multi-resistant bacteria (MRSA, E. faecalis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, P. aeruginosa) that are a problem at hospital level due to the scarce options of active antibiotics.
Herein, the in vitro antimicrobial activity of 13 wild mushrooms aqueous methanolic extracts was screened against the above mentioned multi-resistant bacteria and other clinical isolates from CHTMAD -Hospital Center of Trás-os-Montes and Alto Douro, Portugal.
Materials and methods

Mushroom species
Thirteen mushroom species were collected in different ecosystems of the Trás-osMontes region in the Northeast of Portugal in 2005-2010 Autumns ( Table 1) . The morphological identification of the wild macrofungi was made according to macro and microscopic characteristics, and following several authors (Marchand 1971; Moser 1983; Bon 1988; Courtecuisse and Duhem 2005) and online keys (http://www.mycokey.com/). Representative voucher specimens were deposited at the herbarium of Escola Superior Agrária of Instituto Politécnico de Bragança. After taxonomic identification, the mushrooms were immediately lyophilized (Ly-8-FM-ULE, Snijders, Netherlands) and kept in the dark in hermetically sealed plastic bags up to the point of analysis.
Standards and Reagents
Methanol was of analytical grade purity from Lab-Scan (Lisbon, Portugal). The culture 
Extracts preparation
Each mushroom lyophilized sample (ca. 3 g) was extracted using a methanol:water (80:20; 30 ml) mixture at -20 °C for 6 h. After 15 min in an ultrasonic bath, the extract was centrifuged at 4000 g for 10 min and filtered through Whatman nº 4 paper. The residue was then extracted with two additional 30 ml portions of the methanol:water 6 mixture. The combined extracts were evaporated at 40 ºC under reduced pressure to remove methanol (rotary evaporator Büchi R-210, Flawil, Switzerland), lyophilized, redissolved in water, at a concentration of 200 mg/ml, and stored at -20 ºC for further use.
Microorganisms and culture media
The microorganisms used were clinical isolates from patients hospitalized in various Muller Hinton broth (MHB) and Wilkins-Chalgren Broth (WCB) were used for determination of Minimum Inhibitory Concentration (MIC, lowest concentration of the mushroom extract able to inhibit bacterial growth), while Columbia agar with 5% horse blood (CA) was used for determination of Minimum Bactericidal Concentration (MBC, the lowest concentration of mushroom extract at which bacterial growth was prevented, and the initial viability was reduced by at least 99.9 %).
Characterization of antibiotic susceptibility of target strains
The characterization of antibiotic susceptibility and the identification of the target strains were performed using MicroScan® panels (Siemens). These panels allow the simultaneous determination of susceptibility to antimicrobial agents and the strain identification, including aerobic and facultative anaerobic Gram negative bacilli 
Results
Analysis of antibiotic susceptibility showed that some of the clinical isolates used in the present work are multi-resistant bacteria (Tables 2 and 3) being a problem at hospital level due to the scarce options of active antibiotics. A. baumannii and M. morgani are the Gram negative bacteria with the highest number of resistances, being evident their low sensibility to beta-lactamics group. E. coli shows some resistance to beta-lactamics antibiotics, but also to quinolones group. Furthermore, the latter group shows low activity against P. mirabilis ( In the current study none of the tested extracts inhibited A. baumannii, K. pneumonia or P.
aeruginosa. However, Lepista nuda extract showed some antimicrobial activity against P. mirabilis and P. multocida with MIC values of 20 mg/ml and 5 mg/ml, respectively. This extract was completely inactive for the other tested bacilli (E. coli, K. pneumonia and P. aeruginosa) which is in agreement with the reported by Barros et al. (2008b) for the same mushrooms species. Russula delica and Fistulina hepatica extracts exhibited antimicrobial activity against E. coli, M. morganni and P. multocida at the highest tested concentration (20 mg/ml). Leucopaxillus giganteus extract also revealed activity against E. coli, P. mirabilis (MICs 20 mg/ml) and P. multocida (MIC 10 mg/ml) ( Table   4) .
Among the tested Gram negative bacteria, P. multocida was the most susceptible to the extracts.
The results obtained in the screening of antimicrobial activity of the different wild mushrooms extracts against Gram positive bacteria are shown in Table 5 . Agaricus arvensis extract showed the lowest antimicrobial activity, being only effective against S.
pyogenes (MIC 10 mg/ml). As observed for Gram negative bacteria, Russula delica and Cantharellus cibarius, Lepista nuda and Ramaria botrytis extracts did not show any activity against S. aureus and MRSA, at the tested concentrations (up to 20 mg/ml).
Nevertheless, a previous report described high antimicrobial activity of those species against S. aureus isolated from pus (MIC 5 mg/ml) (Barros et al. 2008b) . It should be highlighted that the authors used a different extraction solvent (methanol), a different antimicrobial activity assay (agar streak dilution method based on radial diffusion), they dissolved the extracts in DMSO and not in water as in the present study, and specially they used a different strain, probably with a different antibiotic resistance profile.
A bactericidal effect of some of the studied mushrooms extracts was observed for the streptococci and P. multocida ( 
Discussion
The obtained results seem to be promising since some extracts were bacteriostatic for 
S na 2 S na S-Susceptible; I-Intermediate; R-Resistant (this classification was made according to the interpretative breakpoints suggested by Clinical and Laboratory Standards Institute-CLSI); Blac-Beta-lactamase positive; Pos-positive to Cefoxitin screening; Neg-negative to Cefoxitin screening; na-not applicable. Table 5 . MIC values (mg/ml) of the wild mushrooms extracts against clinical isolates of Gram positive bacteria. Table 6 . MBC values (mg/ml) of the wild mushrooms extracts against three clinical isolates.
MRSA (Methicillin-resistant Staphylococcus aureus).
Staphylococcus aureus
MRSA
(-) MIC > 20 mg/ml Sarcodon imbricatus -10 10
Tricholoma portentosum 10 10 10
